Krystal Biotech Inc. Price to FCF Ratio 2017–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Price to free cash flow (P/FCF) ratio for Krystal Biotech Inc. (KRYS): market cap divided by trailing twelve-month free cash flow. As of March 31, 2026 it is 41.72.

From: 09/30/2025To: 03/31/2026

Stock Price

TTM Free Cash Flow

Price to FCF

Krystal Biotech Inc. Price to FCF Ratio — FAQ

Krystal Biotech Inc. (KRYS) price to fcf ratio over the last 6 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see KRYS's price to fcf ratio history?

The chart and table above show Krystal Biotech Inc.'s price to fcf ratio by year and by quarter, including the growth rate.